Nimustine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nimustine, covering 2018-07-31 to 2018-07-31. Get the full timeline:
Most recent: Clinical Trial Update: Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma [Phase 2]